JiangXi Tianxin Pharm Co Ltd (603235.SS) stock: key figures, P/E, revenue and dividend

Consumer Staples · Packaged Foods & Meats · China · ISIN CNE100005Q89

Price
24.99 CNY
Market cap
10.94 bn CNY
P/E (2025)
18.49
P/S (2025)
4.67
Dividend yield
2.20 %
Net margin
25.23 %
Return on equity (ROE)
12.03 %
Return on assets (ROA)
9.56 %

JiangXi Tianxin Pharm Co Ltd financials

Fiscal year20242025
Revenue2.21 bn CNY2.35 bn CNY
Gross profit927.85 m CNY992.23 m CNY
Operating income667.61 m CNY689.36 m CNY
EBIT774.25 m CNY704.90 m CNY
Net income651.22 m CNY591.58 m CNY
Diluted EPS – continuing operations1.49 CNY1.35 CNY

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About JiangXi Tianxin Pharm Co Ltd

JiangXi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. The company offers products of vitamin B6, vitamin B1, Vitamin B5, Vitamin D3, pyridoxine hydrochloride CD grade, thiamine nitrate DC grade, folic acid, biotin, ascorbyl palmitate, vitamin E 500, a-acetyl-"-butyrolactone, ABL, cholesterol, L-alanine, and vitamin D3 for use as bulk pharmaceutical chemicals, API, food additives, and feed additives, as well as in other fields. JiangXi Tianxin Pharmaceutical Co., Ltd. was founded in 2004 and is based in Leping, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.